NCT06066294View on ClinicalTrials.gov

A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved.

PHASE3RecruitingINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2024

Conditions
Vaccine Reaction
Interventions
BIOLOGICAL

Regimen 1

WHO Pre-qualified rabies vaccine (Rabivax-S), WHO recommended PrEP Vaccination Schedule, 2 visits, 0.2ml 2 sites (0.1ml each site) on day 0 and day 7

BIOLOGICAL

Regimen 2

WHO Pre-qualified rabies vaccine (Rabivax-S), Government of India approved vaccination schedule, 3 visits, 0.1ml 1 site on day 0, 7 and 28

Trial Locations (1)

560002

RECRUITING

Kempegowda Institute Of Medical Sciences Hospital and Research Center, Bengaluru

All Listed Sponsors
lead

Kempegowda Institute of Medical Sciences, Bangalore

OTHER_GOV